Two studies on a novel Focal Adhesion Kinase inhibitor just got published: with a strong contribution from @ErasmusOncology https://t.co/E461RuLQXE https://t.co/DB6G3I2YQn
435 followers
435 followers
RT @martijn_lolkema: Back 2 Back publication of a two #PhaseI trials of a Focal Adhesion Kinase inhibitor. @Boehringer @ErasmusOncology @NK…
502 followers
Back 2 Back publication of a two #PhaseI trials of a Focal Adhesion Kinase inhibitor. @Boehringer @ErasmusOncology @NKI_nl @UMCUtrecht @pmcancercentre Juravinski Cancer Centre. Successful Canadian/ Dutch collaboration. https://t.co/nEpC01Zped https://t.c
291 followers
Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520 https://t.co/jczCZGqs9S https://t.co/7octn5kWkH